Evicenter
P&T meetings

Ivonescimab

EGFR-mutated non-small-cell lung cancer

Launch
Not announced
Last updated
79 sources

Product information and disease descriptionPlace of product in therapy

Approaches to treatment

18 evidence topics · 17 sources

Other product development or post-marketing obligations required by the FDA

No evidence found.

Ongoing post-approval monitoring

No evidence found.